“The question early on was what mechanisms we wanted,” Madrigal CEO Bill Sibold told Fierce in an interview at the company’s ...

Madrigal reported second quarter revenues of $364.3 million, up 71% year-on-year and up 17% sequentially. Read why MDGL stock is upgraded to a hold.

D&D Pharmaceuticals, a South Korean clinical-stage biopharmaceutical company focused on developing medicines for metabolic, fibrotic, and neurodegenerative diseases, has recently published new data ...

Startup is using Bitcoin and the Lightning Network to enable flexible, usage-based monetization of digital apps, widgets, tools, online content, and other experiences based on quality and value Mash ...